Yahoo Finance

Trinity Biotech's Redesigned CGM Sensor Favored by New Clinical Data

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Yahoo Finance

Trinity Biotech Reports Landmark First-Day Accuracy Gains in CGM Pre-Pivotal Trial

DUBLIN, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including ...

Blood glucose monitoring vs continuous glucose monitoring: What should a diabetic choose?

Traditional Blood Glucose Monitoring (BGM) provides a single snapshot of your blood sugar at one exact moment, whereas ...
CNET

The FDA Just Cleared the Dexcom G7 15-Day, the Longest-Lasting CGM Wearable

The US Food and Drug Administration has cleared the Dexcom G7 15-Day Continuous Glucose Monitor (CGM) for people older than 18 with diabetes. It’s the longest-lasting wearable on the market. The G7 15 ...
Healio

FDA clears implantable CGM with sensor that lasts up to 1 year

Please provide your email address to receive an email when new articles are posted on . The FDA has cleared the Eversense 365 CGM for adults with type 1 or type 2 diabetes. The system includes an ...
Nasdaq

Eversense 365 Receives FDA Clearance: The World’s First One Year CGM

With a single sensor, the Eversense 365 system provides one year of use, versus 10-14 days with short-term CGM’s for minimal life disruption “Managing diabetes can be stressful and it is important for ...
MobiHealthNews

Eversense CGM system sensors recalled due to manufacturing error

The FDA has issued a class two device recall for Senseonics’ Eversense continuous glucose monitoring system. This posting follows a September notice from the company that alerted providers and ...
Medscape

CGM Metrics Can Improve Prognosis Insights Beyond A1c in T1D

In patients with T1D, certain CGM metrics can provide information on the risk for severe hypoglycemia independent of A1c and ...
MD&M East

Trinity Biotech Sees Progress for Redesigned CGM Sensor

Trinity Biotech is making a serious play in the continuous glucose monitoring space. The Dublin-based company announced positive clinical trial results demonstrating a major technical breakthrough and ...
Nasdaq

Real-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open and Closed Loop Systems

Eversense 365 delivered favorable glucometrics compared to other open and closed loop systems, validating the one-year CGM’s differentiated approach and high performance New data expands on findings ...
Business Wire

Eversense 365 Receives FDA Clearance: The World’s First One Year CGM

With a single sensor, the Eversense 365 system provides one year of use, versus 10-14 days with short-term CGM’s for minimal life disruption “The approval of Eversense 365 represents a significant ...